PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more
PULSION Medical Systems SE (PUS) - Net Assets
Latest net assets as of December 2017: €20.60 Million EUR
Based on the latest financial reports, PULSION Medical Systems SE (PUS) has net assets worth €20.60 Million EUR as of December 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€35.15 Million) and total liabilities (€14.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €20.60 Million |
| % of Total Assets | 58.62% |
| Annual Growth Rate | 20.77% |
| 5-Year Change | -1.62% |
| 10-Year Change | 2.64% |
| Growth Volatility | 764.11 |
PULSION Medical Systems SE - Net Assets Trend (2000–2024)
This chart illustrates how PULSION Medical Systems SE's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PULSION Medical Systems SE (2000–2024)
The table below shows the annual net assets of PULSION Medical Systems SE from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €21.15 Million | +2.64% |
| 2023-12-31 | €20.60 Million | -12.54% |
| 2022-12-31 | €23.56 Million | +4.38% |
| 2021-12-31 | €22.57 Million | +5.00% |
| 2020-12-31 | €21.49 Million | +0.57% |
| 2019-12-31 | €21.37 Million | +3.74% |
| 2018-12-31 | €20.60 Million | 0.00% |
| 2017-12-31 | €20.60 Million | 0.00% |
| 2016-12-31 | €20.60 Million | +0.00% |
| 2015-12-31 | €20.60 Million | +17.13% |
| 2013-12-31 | €17.59 Million | -26.22% |
| 2012-12-31 | €23.84 Million | +12.99% |
| 2011-12-31 | €21.10 Million | +27.40% |
| 2010-12-31 | €16.56 Million | -2.48% |
| 2009-12-31 | €16.98 Million | +4.56% |
| 2008-12-31 | €16.24 Million | -4.77% |
| 2007-12-31 | €17.05 Million | +16.59% |
| 2006-12-31 | €14.63 Million | +29.98% |
| 2005-12-31 | €11.25 Million | +22.28% |
| 2004-12-31 | €9.20 Million | +10.69% |
| 2003-12-31 | €8.31 Million | +12.78% |
| 2002-12-31 | €7.37 Million | -16.05% |
| 2001-12-31 | €8.78 Million | +3751.32% |
| 2000-12-31 | €228.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to PULSION Medical Systems SE's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 852930245.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €8.53 Million | 40.34% |
| Other Components | €12.62 Million | 59.66% |
| Total Equity | €21.15 Million | 100.00% |
PULSION Medical Systems SE Competitors by Market Cap
The table below lists competitors of PULSION Medical Systems SE ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RiverBank Holding Company
PINK:RBNK
|
$201.93K |
|
EFG INTL N (E2S.SG)
STU:E2S
|
$202.02K |
|
Premier Foods PLC
LSE:PFD
|
$202.13K |
|
NTT DATA - Dusseldorf Stock Exchang
DU:NT5
|
$202.18K |
|
Rathdowney Resources Ltd
PINK:RATHF
|
$201.47K |
|
TOBA Investments Equities
CO:TOIEQT
|
$201.40K |
|
DTE Energy Co Pref Series E
NYSE:DTW
|
$201.17K |
|
Nvni Group Limited Warrants
NASDAQ:NVNIW
|
$201.01K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PULSION Medical Systems SE's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 20,600,954 to 21,145,656, a change of 544,702 (2.6%).
- Net income of 544,702 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €544.70K | +2.58% |
| Total Change | €- | 2.64% |
Book Value vs Market Value Analysis
This analysis compares PULSION Medical Systems SE's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 8.64x to 8.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €2.50 | €21.60 | x |
| 2018-12-31 | €2.50 | €21.60 | x |
| 2019-12-31 | €2.59 | €21.60 | x |
| 2020-12-31 | €2.61 | €21.60 | x |
| 2021-12-31 | €2.74 | €21.60 | x |
| 2022-12-31 | €2.86 | €21.60 | x |
| 2023-12-31 | €2.50 | €21.60 | x |
| 2024-12-31 | €2.56 | €21.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PULSION Medical Systems SE utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.58%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.36%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.89x
- Recent ROE (2.58%) is below the historical average (18.59%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 9.40% | 5.21% | 0.93x | 1.93x | €-54.20K |
| 2005 | 17.36% | 9.46% | 1.02x | 1.80x | €810.20K |
| 2006 | 22.75% | 13.29% | 1.08x | 1.59x | €1.82 Million |
| 2007 | 15.02% | 8.90% | 1.05x | 1.60x | €840.80K |
| 2009 | 2.80% | 1.65% | 1.09x | 1.55x | €-1.20 Million |
| 2010 | 17.23% | 9.06% | 1.22x | 1.55x | €1.20 Million |
| 2011 | 21.76% | 13.87% | 1.11x | 1.42x | €2.47 Million |
| 2012 | 29.64% | 20.30% | 1.08x | 1.36x | €4.66 Million |
| 2013 | 43.12% | 20.57% | 1.39x | 1.50x | €5.76 Million |
| 2015 | 172.75% | 137.54% | 0.39x | 3.20x | €33.53 Million |
| 2016 | 0.00% | 0.00% | 0.70x | 1.70x | €-2.06 Million |
| 2017 | 0.00% | 0.00% | 0.73x | 1.71x | €-2.06 Million |
| 2018 | 0.00% | 0.00% | 0.71x | 1.68x | €-2.06 Million |
| 2019 | 3.61% | 3.02% | 0.83x | 1.44x | €-1.37 Million |
| 2020 | 0.57% | 0.38% | 0.94x | 1.58x | €-2.03 Million |
| 2021 | 4.76% | 3.84% | 0.89x | 1.39x | €-1.18 Million |
| 2022 | 4.19% | 3.33% | 0.87x | 1.44x | €-1.37 Million |
| 2023 | -14.34% | -8.25% | 1.07x | 1.63x | €-5.01 Million |
| 2024 | 2.58% | 1.36% | 1.00x | 1.89x | €-1.57 Million |
Industry Comparison
This section compares PULSION Medical Systems SE's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PULSION Medical Systems SE (PUS) | €20.60 Million | 9.40% | 0.71x | $201.83K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |